IGFBP1 has been shown to be a metabolic regulator under stress conditions in some cancer types (Inagaki et al., 2008; Seferovic et al., 2009), and enhanced glycolytic capacity is considered to be a hallmark of cancer. The gene discussed is IGFBP1; the disease is cancer.